Class II
Terminated
BUFFERED LIDOCAINE 1%+EPI 1:100,000 INJ SOL, [3ML NDC: 70731-0137-03 and 30ML NDC: 70731-0137-30] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0137-03
Why: Lack of Assurance of Sterility
- Company
- RXQ Compounding LLC
Athens, OH, United States - Reported
- Aug 14, 2019
- Recall started
- Jun 19, 2019
- Ended
- Sep 16, 2022
- Where sold
- Nationwide USA
- Amount
- N/A
- Full product description
- BUFFERED LIDOCAINE 1%+EPI 1:100,000 INJ SOL, [3ML NDC: 70731-0137-03 and 30ML NDC: 70731-0137-30] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0137-03
- Lots / codes affected
- All lots within expiry
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.